BOC Group Once Again Selected as a Leader in the Magic Quadrant of Gartner Enterprise Architecture Tools
PR Newswire
1h ago
Ai Focus
BOC Group indicates that the company has once again been rated as a leader in Gartner ®'The Magic Quadrant of Enterprise Architecture Tools™', which is also its sixth consecutive year of receiving this recognition. The company states that the ADOIT EA suite helps architecture teams to better manage dependencies, technical risks, and decision support in the transformation driven by AI.
Helpful
No.Help

Dublin, November 3rd / PRNewswire / -- Global enterprise modeling software provider BOC Group has once again been recognized as a leader in Gartner ®The Magic Quadrant™ for Enterprise Architecture Tools¹. This is the sixth time in a row that the company has received this recognition, highlighting the continued momentum of ADOIT EA suite as organizations strive to undertake transformations driven by AI.

ADOIT Helps the architecture team transform static documents into a dynamic, interconnected knowledge base, thereby supporting real-time decision-making. Guided workspaces and simple forms make it easier for architecture data to be contributed, reviewed, and used throughout the organization, helping professionals shift their focus from data entry to more valuable tasks.

A key part of this evolution is to directly integrate AI into daily architectural work. ADOIT helps teams interact with architectural knowledge using natural language, identify dependencies and technical risks, and more quickly transform corporate data into actionable insights, while always maintaining a credible architectural context at the core.

ADOIT Product Manager Christoph Moser said, "We are very proud to have been recognized as leaders for six consecutive years. As AI reshapes the company, it is essential for the organization to have a clear understanding of its own technology, dependencies, and the impact of change. Our focus at ADOIT is to provide architects with this context, as well as tools to turn it into confident action."

More information about BOC Group and ADOIT can be found on the ADOIT website.

Gartner Disclaimer

Gartner does not endorse any companies, suppliers, products, or services described in its publications, nor does it recommend that technical users choose only those with the highest ratings or other specified suppliers. Gartner The publications represent solely the views of Gartner the Business and Technology Insights organization and should not be regarded as statements of fact. Gartner No express or implied warranties are provided regarding these publications, including any warranties of suitability for sale or for a particular purpose.

GARTNER and MAGIC QUADRANT are trademarks of Gartner, Inc and/or their affiliated companies.

¹ Gartner, Magic Quadrant, for, Enterprise Architecture Tools, Austin Steinmetz, Rowan Wakeford, Rhyan Light, October 13, 2026.

About BOC Group

BOC Group designs and sells enterprise modeling software for BPM, EA, and GRC, helping organizations manage complexity and undergo transformation in the digital age. Its interconnected and adaptable tools can be integrated with a wide range of ecosystem applications.

Customers of ADOIT include numerous enterprises such as Allianz, Dubai Airports, Coca - Cola Beverages Africa, PostFinance, NielsenIQ, and others.

Contact Information

BOC Information Technologies Consulting GmbH

Michael Kamberov

Global Market Development Manager

+43-1-905 10 71-0

Tip
$0
Like
0
Save
0
Views 13
HQYC reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
Ethereum is a "tokenized toll road": Reasons why Joseph Chalom is bullish on ETH
SharpLink CEO Joseph Chalom stated that the long-term logic of ETH is strengthening, and the key is no longer a single catalyst, but rather the speed of blockchain on Wall Street. He proposed three indicators for observation: the supply of stablecoins, the scale of tokenized stocks, and the volume of payment transactions between AI agents.
Coinpedia
·2026-11-03 19:35:50
0
Clarivate Announces Third Quarter 2026 Results, Calling It a Clear Path to Value Creation
Clarivate releases third-quarter results as of September 30, 2026. The company stated that driven by portfolio adjustments and AI-initiated innovation, recurring organic revenue growth has improved, and the annual contract value ( ACV ) of its intellectual property business has resumed growth. Additionally, the company completed the divestiture of its life sciences and healthcare business on October 6 and updated its financial outlook for 2026.
PR Newswire
·2026-11-03 19:24:26
10
Waters Corporation Announces Financial Results for the Third Quarter of 2026
Waters Corporation Announces Financial Results for the Third Quarter of 2026: Revenue of $1.767 Billion, Adjusted Earnings Per Share of $4.10; The Company Upsits Its Annual Revenue and Adjusted Earnings Per Share Guidance for 2026, and Indicates That It Will Provide a Growth Framework for 2027 During the Earnings Call.
PR Newswire
·2026-11-03 19:15:16
19
Clarivate Announces Third Quarter 2026 Results, Claiming to Have Paved a Clear Path for Value Creation
Clarivate Announces Third Quarter 2026 Results, Says Recurrent Organic Revenue Growth Improves Driven by Portfolio Adjustment and AI-Driven Innovation; Intellectual Property Business ACV Resumes Positive Growth; Company Also Updates 2026 Financial Prospects and Completes Sale of Life Sciences and Healthcare Business.
PR Newswire
·2026-11-03 19:15:14
18
Little-known biotech company Genmab sees success with high-risk cancer treatment bets; stock price doubles in three months
Danish biotech company Genmab has seen its stock price double within three months following a series of successful cancer drug trials. The company stated that these breakthroughs have provided new momentum for its strategy to shift from relying on royalty income to taking more control over the ownership and sales revenue of its own developed drugs.
CNBC
·2026-11-03 19:15:12
20
View More